Tubuloside A, a phenylethanoid glycoside, alleviates diclofenac induced hepato‐nephro oxidative injury via Nrf2/HO‐1
Journal of Cellular and Molecular Medicine · 2023
DOI: 10.1111/jcmm.17968 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Cellular and Molecular Medicine, 2023. Verfasst von Ali Tureyen und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Gastroenterology, Ministry of Health Eskisehir City Hospital, Eskisehir, Turkey. Hauptthemen laut MEDLINE: Diclofenac, Glycosides, NF-E2-Related Factor 2. Die Arbeit wurde bisher 24-mal zitiert (Crossref) und nennt 48 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
The most prominent adverse effects of nonsteroidal anti‐inflammatory drugs (NSAIDs) such as diclofenac (DF) are hepato‐renal damage. Natural antioxidants can be preferred as an alternative and/or combination to improve this damage. This present study was conducted to evaluate the protective effect of Tubuloside A (TA) against diclofenac (DF)‐induced hepato‐renal damage. TA (1 mg/kg, ip) was administered to male Sprague–Dawley rats for 5 days, and DF (50 mg/kg, ip) was administered on Days 4 and 5. Plasma aspartate amino transferase, alanine amino transferase, alkaline phosphatase, blood urea nitrogen and creatinine were measured to evaluate liver and kidney functions. Additionally, oxidative stress parameters (malondialdehyde, glutathione, superoxide dismutase, catalase, and 8‐oxo‐7,8‐dihydro‐2′‐deoxyguanosine) in blood, liver, and kidney tissues, changes in mRNA expression of genes involved in the Nrf2 / HO ‐ 1 signalling pathway ( Nrf2 , HO ‐ 1 , NQO ‐ 1 , IL ‐ 6 , iNOS , Cox ‐ 2 , TNF ‐ α , IL1 ‐ β and NFκB ) and apoptotic process ( Bcl ‐ 2 , Cas ‐ 3 and Bax ) in liver and kidney tissues were determined. Additionally, tissue sections were evaluated histopathologically. Biochemical, histopathological, and molecular results demonstrated the hepato‐renal toxic effects of DF, and TA treatment protected the liver and kidney from DF‐induced damage. This provides an explanation for the hepato‐nephro damage caused by DF and offers new ideas and drug targets together with TA for the prevention and treatment of DF injury.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Gastroenterology, Ministry of Health Eskisehir City Hospital, Eskisehir, Turkey.
- Bayat Vocational School, Afyon Kocatepe University, Afyonkarahisar, Turkey.
- Faculty of Veterinary Medicine, Department of Physiology, Afyon Kocatepe University, Afyonkarahisar, Turkey.
- Department of Biochemistry, Faculty of Veterinary Medicine, Afyon Kocatepe University, Afyonkarahisar, Turkey.
- Department of Pharmacology and Toxicology, Faculty of Veterinary Medicine, Afyon Kocatepe University, Afyonkarahisar, Turkey.
ORCID-Profile: Sinan Ince
Zitieren
APA
Tureyen, A., Demirel, H. H., Demirkapi, E. N., Eryavuz, A. M., & Ince, S. (2023). Tubuloside A, a phenylethanoid glycoside, alleviates diclofenac induced hepato‐nephro oxidative injury via Nrf2/HO‐1. Journal of Cellular and Molecular Medicine. https://doi.org/10.1111/jcmm.17968
Vancouver
Tureyen A, Demirel HH, Demirkapi EN, Eryavuz AM, Ince S. Tubuloside A, a phenylethanoid glycoside, alleviates diclofenac induced hepato‐nephro oxidative injury via Nrf2/HO‐1. Journal of Cellular and Molecular Medicine. 2023. doi:10.1111/jcmm.17968
BibTeX
@article{Tureyen2023,
author = {Tureyen, Ali and Demirel, Hasan Huseyin and Demirkapi, Ezgi Nur and Eryavuz, Azra Mila and Ince, Sinan},
title = {Tubuloside A, a phenylethanoid glycoside, alleviates diclofenac induced hepato‐nephro oxidative injury via Nrf2/HO‐1},
journal = {Journal of Cellular and Molecular Medicine},
year = {2023},
doi = {10.1111/jcmm.17968}
}
EUVIMED